|
SS/SB 668 - This act requires that insurers that offer benefits for cancer treatment offer oral anticancer medication at terms at least as favorable as intravenously administered anticancer medications. Health benefit plans can be in compliance with this section if orally prescribed anticancer medications are offered at a rate that limits total out-of-pocket costs to seventy-five dollars for a thirty day period, and high deductible plans can meet these compliance terms after the satisfaction of the annual deductible. This act is similar to SB 663 (2014). MICHELA BIRK
|
